HomeStock ScreenerAptus Pharma

Aptus Pharma Share Price | Aptus Pharma Stock Screener

APPL Household Appliances
Track Aptus Pharma share price live with TickJournal's free stock screener. Check APPL annual price range for the annual price range and momentum. Use the Aptus Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Aptus Pharma Market Cap ₹305.30 Cr.
APPL P/E Ratio (TTM) -
Aptus Pharma P/B Ratio 15.40
EPS (TTM) ₹7.78
Dividend Yield -
Debt to Equity 1.79
APPL 52 Week High -
Aptus Pharma 52 Week Low -
Operating Margin -
Profit Margin -
APPL Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹44.00
Total Equity ₹23.00

Aptus Pharma Share Price Chart

Screen Aptus Pharma share price with an interactive chart. Analyse APPL price trends and volatility across different timeframes.

Aptus Pharma Company Profile - Fundamental Screener

Screen Aptus Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for APPL shares.
Sector Consumer Goods
Industry Household Appliances
Sub-Sector Household Appliances
Segment E
ISIN INE15XJ01010

Aptus Pharma Balance Sheet Screener

Screen APPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023
Assets
Total Assets 44 22 10 6
Current Assets 35 20 8 6
Fixed Assets 3 1 1 1
Liabilities
Total Liabilities 0 0 0 0
Current Liabilities 1 3 4 2
Non-Current Liabilities 0 0 0 0
Shareholders' Equity
Total Equity 23 7 2 1
Share Capital 7 5 0 0
Reserves & Surplus 17 2 2 1

Aptus Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Aptus Pharma income statement and profit fundamentals. Analyze APPL quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Aptus Pharma share price evaluation.
Item None-None 2026-March 2025-March 2024-March 2023-March
Revenue 0 47 25 18 14
Expenses 0 39 20 16 13
EBITDA 0 7 5 2 1
Operating Profit % 0.00% 16.00% 20.00% 9.00% 4.00%
Depreciation 0 0 0 0 0
Interest 0 1 1 0 0
Profit Before Tax 0 6 4 1 0
Tax 0 2 1 0 0
Net Profit 0 5 3 1 0
EPS 0.00 7.78 6.37 5.32 1.30

Aptus Pharma Cash Flow Screener - Liquidity Fundamentals

Screen APPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March
Operating Activities -2 -2 0
Investing Activities -1 0 0
Financing Activities 7 3 1
Net Cash Flow 4 0 0

Aptus Pharma Shareholding Pattern Screener

See Aptus Pharma shareholding pattern with promoter, FII, and DII holdings. Check Aptus Pharma promoter holding and ownership changes for APPL on TickJournal.
Item 2026-May 2026-Mar 2025-Dec 2025-Sept 2025-Jun
Promoter Holding 72.89% 72.89% 72.89% 72.89% 72.89%
FII Holding 0.00% 0.00% 0.00% 10.03% 10.03%
DII Holding 0.00% 0.00% 0.00% 2.80% 2.80%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.76% 23.47% 22.97% 11.55% 11.55%
Other Holding 3.35% 3.64% 4.14% 2.74% 2.74%
Shareholder Count 356 337 302 9 9

Aptus Pharma Share Dividend Screener - Share Yield Analysis

Check Aptus Pharma dividend history with payout and yield data. View Aptus Pharma dividend details including ex-dates and amounts for APPL stock.
No dividends declared by Aptus Pharma.

Aptus Pharma Stock Index Membership

See which indices include Aptus Pharma stock. Check APPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Aptus Pharma is not part of any tracked indices.
Only major market indices are tracked in our system.

Aptus Pharma Market Events Screener - Corporate Actions

Get Aptus Pharma corporate actions including splits, bonuses, and buybacks. Check Aptus Pharma stock events that may affect APPL share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-12 2026-05-12 Bonus 3:2 16.32%
2026-04-27 2026-04-27 Quarterly Result Announcement NA -4.87%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 12.62%

Aptus Pharma Competitors Screener - Peer Comparison

Screen APPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
LG Electronics 102,997 61.79 24,605 -0.10% 1,680 47.61
Voltas 42,069 113.39 14,123 -10.26% 365 41.75
Blue Star 33,739 64.62 12,402 2.98% 545 39.81
Amber Enterprises 25,732 114.40 12,187 21.30% 223 43.14
Crompton Greaves 18,612 -82.30 8,096 2.06% -258 57.53
V-Guard Industries 13,734 43.23 5,966 6.56% 302 44.12
Whirlpool 10,849 36.35 8,034 -0.94% 282 42.30
Eureka Forbes 8,877 55.15 2,709 10.51% 161 36.57
TTK Prestige 7,023 47.06 2,974 6.60% 152 47.43
Symphony 4,900 -34.63 1,131 -30.30% -150 36.18

Aptus Pharma Company Announcements - News Screener

Screen APPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-05-26 Brand Promotion Initiative At Rajkot Hirasar Airport -
2026-05-15 Disclosure As Per Regulation 7(2) Of SEBI (PIT) Regulations 2015 -
2026-05-14 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-14 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-14 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-14 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-14 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-14 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-13 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-13 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-13 Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations 2011 -
2026-05-06 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-04-28 Statement Of Deviation(S) Or Variation(S) In Utilization Of Proceeds Of Initial Public Offer Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-04-28 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-04-27 Intimation Of Record Date For Issue Of Bonus Shares -
2026-04-27 Audited Financial Results For The Half Year And Year Ended On 31St March 2026 -
2026-04-27 Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th April 2026. -
2026-04-25 Disclosure Regarding Non-Applicability Of Regulation 24A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-04-25 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-04-20 Board Meeting Intimation for Intimation Of Board Meeting For Consideration Of Audited Financial Results For The Half Year/Year Ended On March 31 2026 And Closure Of Trading Window. -